U.S. flag

An official website of the United States government

PMC Full-Text Search Results

Items: 3

1.
Figure 2

Figure 2 . From: Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases.

Kaplan-Meier analysis of intracranial control after SRT/SRS treatment of a brainstem metastasis. The median time to distant intracranial failure was 2.1 months.

Jonathan E Leeman, et al. Radiat Oncol. 2012;7:107-107.
2.
Figure 3

Figure 3 . From: Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases.

Kaplan-Meier analysis of overall survival after SRT/SRS treatment of a brainstem metastasis. Median overall survival was found to be 3 months.

Jonathan E Leeman, et al. Radiat Oncol. 2012;7:107-107.
3.
Figure 1

Figure 1 . From: Prescription dose and fractionation predict improved survival after stereotactic radiotherapy for brainstem metastases.

Kaplan-Meier analysis of local control after SRT/SRS treatment of a brainstem metastasis. The 6 month and 12 month actuarial control rates were 93%.

Jonathan E Leeman, et al. Radiat Oncol. 2012;7:107-107.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Support Center